1. Home
  2. BJDX vs ATCH Comparison

BJDX vs ATCH Comparison

Compare BJDX & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • ATCH
  • Stock Information
  • Founded
  • BJDX 2015
  • ATCH 2022
  • Country
  • BJDX United States
  • ATCH United States
  • Employees
  • BJDX N/A
  • ATCH N/A
  • Industry
  • BJDX Medical Specialities
  • ATCH
  • Sector
  • BJDX Health Care
  • ATCH
  • Exchange
  • BJDX Nasdaq
  • ATCH Nasdaq
  • Market Cap
  • BJDX 2.9M
  • ATCH 3.0M
  • IPO Year
  • BJDX 2021
  • ATCH N/A
  • Fundamental
  • Price
  • BJDX $1.58
  • ATCH $0.19
  • Analyst Decision
  • BJDX
  • ATCH
  • Analyst Count
  • BJDX 0
  • ATCH 0
  • Target Price
  • BJDX N/A
  • ATCH N/A
  • AVG Volume (30 Days)
  • BJDX 2.1M
  • ATCH 2.7M
  • Earning Date
  • BJDX 08-13-2025
  • ATCH 05-16-2025
  • Dividend Yield
  • BJDX N/A
  • ATCH N/A
  • EPS Growth
  • BJDX N/A
  • ATCH N/A
  • EPS
  • BJDX N/A
  • ATCH 2.67
  • Revenue
  • BJDX N/A
  • ATCH N/A
  • Revenue This Year
  • BJDX N/A
  • ATCH N/A
  • Revenue Next Year
  • BJDX $55.56
  • ATCH N/A
  • P/E Ratio
  • BJDX N/A
  • ATCH $0.07
  • Revenue Growth
  • BJDX N/A
  • ATCH N/A
  • 52 Week Low
  • BJDX $1.46
  • ATCH $0.18
  • 52 Week High
  • BJDX $44.50
  • ATCH $66.00
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 42.16
  • ATCH 34.16
  • Support Level
  • BJDX $1.49
  • ATCH $0.18
  • Resistance Level
  • BJDX $1.63
  • ATCH $0.20
  • Average True Range (ATR)
  • BJDX 0.16
  • ATCH 0.02
  • MACD
  • BJDX -0.00
  • ATCH 0.01
  • Stochastic Oscillator
  • BJDX 7.29
  • ATCH 10.53

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: